These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis. Svensson E; Eriksson H; Gekas C; Olofsson T; Richter J; Gullberg U Exp Cell Res; 2005 Aug; 308(1):211-21. PubMed ID: 15907324 [TBL] [Abstract][Full Text] [Related]
3. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells. Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505 [TBL] [Abstract][Full Text] [Related]
4. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells. Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770 [TBL] [Abstract][Full Text] [Related]
5. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170 [TBL] [Abstract][Full Text] [Related]
6. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis. Hosen N; Shirakata T; Nishida S; Yanagihara M; Tsuboi A; Kawakami M; Oji Y; Oka Y; Okabe M; Tan B; Sugiyama H; Weissman IL Leukemia; 2007 Aug; 21(8):1783-91. PubMed ID: 17525726 [TBL] [Abstract][Full Text] [Related]
7. Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells. Svedberg H; Richter J; Gullberg U Leukemia; 2001 Dec; 15(12):1914-22. PubMed ID: 11753613 [TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action? Olszewski M; Huang W; Chou PM; Duerst R; Kletzel M Cytotherapy; 2005; 7(1):57-61. PubMed ID: 16040384 [TBL] [Abstract][Full Text] [Related]
9. The role of Wilms' tumor genes. Hirose M J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307 [TBL] [Abstract][Full Text] [Related]
10. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis. Baird PN; Simmons PJ Exp Hematol; 1997 Apr; 25(4):312-20. PubMed ID: 9131006 [TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095 [TBL] [Abstract][Full Text] [Related]
12. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Han Y; San-Marina S; Yang L; Khoury H; Minden MD Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147 [TBL] [Abstract][Full Text] [Related]
13. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro. Maurer U; Brieger J; Weidmann E; Mitrou PS; Hoelzer D; Bergmann L Exp Hematol; 1997 Aug; 25(9):945-50. PubMed ID: 9257807 [TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4]. Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579 [TBL] [Abstract][Full Text] [Related]
15. Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineage. Järås M; Johnels P; Agerstam H; Lassen C; Rissler M; Edén P; Cammenga J; Olofsson T; Bjerrum OW; Richter J; Fan X; Fioretos T Exp Hematol; 2009 Mar; 37(3):367-75. PubMed ID: 19135771 [TBL] [Abstract][Full Text] [Related]
16. [Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro]. Gu WY; Chen ZX; Qiu GQ; Hu SY; Jia L; Wu W; He J; Cen JN; He B Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3401-6. PubMed ID: 19159569 [TBL] [Abstract][Full Text] [Related]
17. The Wilms' tumor gene 1 (WT1) induces expression of the N-myc downstream regulated gene 2 (NDRG2). Svensson E; Vidovic K; Olofsson T; Vallon-Christersson J; Borg A; Gullberg U DNA Cell Biol; 2007 Aug; 26(8):589-97. PubMed ID: 17688410 [TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain. Deuel TF; Guan LS; Wang ZY Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756 [TBL] [Abstract][Full Text] [Related]
19. The Wilms' tumor gene WT1 is a common marker of progenitor cells in fetal liver. Kanato K; Hosen N; Yanagihara M; Nakagata N; Shirakata T; Nakazawa T; Nishida S; Tsuboi A; Kawakami M; Masuda T; Oka Y; Oji Y; Ijpenberg A; Hastie ND; Sugiyama H Biochem Biophys Res Commun; 2005 Jan; 326(4):836-43. PubMed ID: 15607745 [TBL] [Abstract][Full Text] [Related]
20. Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells. Hosen N; Sonoda Y; Oji Y; Kimura T; Minamiguchi H; Tamaki H; Kawakami M; Asada M; Kanato K; Motomura M; Murakami M; Fujioka T; Masuda T; Kim EH; Tsuboi A; Oka Y; Soma T; Ogawa H; Sugiyama H Br J Haematol; 2002 Feb; 116(2):409-20. PubMed ID: 11841446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]